Structural Insights into the YAP and TEAD Complex

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2010 Feb 4

PMID 20123905

Citations 198

Authors

Ze Li

Bin Zhao

Ping Wang

Fei Chen

Zhenghong Dong

Huirong Yang

Kun-Liang Guan

Yanhui Xu

Affiliations

Soon will be listed here.

Abstract

The Yes-associated protein (YAP) transcriptional coactivator is a key regulator of organ size and a candidate human oncogene inhibited by the Hippo tumor suppressor pathway. The TEAD family of transcription factors binds directly to and mediates YAP-induced gene expression. Here we report the three-dimensional structure of the YAP (residues 50-171)-TEAD1 (residues 194-411) complex, in which YAP wraps around the globular structure of TEAD1 and forms extensive interactions via three highly conserved interfaces. Interface 3, including YAP residues 86-100, is most critical for complex formation. Our study reveals the biochemical nature of the YAP-TEAD interaction, and provides a basis for pharmacological intervention of YAP-TEAD hyperactivation in human diseases.

Citing Articles

Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer.

Arakawa H, Komatsu S, Kiuchi J, Imamura T, Nishibeppu K, Kamiya H Am J Cancer Res. 2025; 15(1):363-374.

PMID: 39949934 PMC: 11815361. DOI: 10.62347/NZMO2658.

The YAP1-MAML2 fusion drives tumorigenesis and sustains tumor growth.

Ni W, Yu M, Yang R, Li J, Zhou X, Calbay O Mol Ther Oncol. 2024; 32(4):200900.

PMID: 39624057 PMC: 11609529. DOI: 10.1016/j.omton.2024.200900.

Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities.

Han Z, Shen Z, Pei J, You Q, Zhang Q, Wang L Acta Pharm Sin B. 2024; 14(10):4243-4265.

PMID: 39525591 PMC: 11544290. DOI: 10.1016/j.apsb.2024.06.019.

Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.

Haripriya E, Hemalatha K, Matada G, Pal R, Das P, Ashadul Sk M Mol Divers. 2024; .

PMID: 39436581 DOI: 10.1007/s11030-024-11009-1.

TLK1>Nek1 Axis Promotes Nuclear Retention and Activation of YAP with Implications for Castration-Resistant Prostate Cancer.

Olatunde D, De Benedetti A Cancers (Basel). 2024; 16(16).

PMID: 39199688 PMC: 11352418. DOI: 10.3390/cancers16162918.

References

Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A . The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell. 2009; 16(3):398-410. DOI: 10.1016/j.devcel.2009.02.003. View

Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A . Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem. 2001; 276(18):15164-73. DOI: 10.1074/jbc.M010484200. View

Halder G, Polaczyk P, Kraus M, Hudson A, Kim J, Laughon A . The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev. 1998; 12(24):3900-9. PMC: 317267. DOI: 10.1101/gad.12.24.3900. View

Westin S, Kurokawa R, Nolte R, Wisely G, McInerney E, Rose D . Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature. 1998; 395(6698):199-202. DOI: 10.1038/26040. View

Adams P, Grosse-Kunstleve R, Hung L, Ioerger T, McCoy A, Moriarty N . PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr. 2002; 58(Pt 11):1948-54. DOI: 10.1107/s0907444902016657. View

Steinhardt A, Gayyed M, Klein A, Dong J, Maitra A, Pan D . Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008; 39(11):1582-9. PMC: 2720436. DOI: 10.1016/j.humpath.2008.04.012. View

Yagi R, Chen L, Shigesada K, Murakami Y, Ito Y . A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999; 18(9):2551-62. PMC: 1171336. DOI: 10.1093/emboj/18.9.2551. View

Zender L, Spector M, Xue W, Flemming P, Cordon-Cardo C, Silke J . Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006; 125(7):1253-67. PMC: 3026384. DOI: 10.1016/j.cell.2006.05.030. View

Fossdal R, Jonasson F, Kristjansdottir G, Kong A, Stefansson H, Gosh S . A novel TEAD1 mutation is the causative allele in Sveinsson's chorioretinal atrophy (helicoid peripapillary chorioretinal degeneration). Hum Mol Genet. 2004; 13(9):975-81. DOI: 10.1093/hmg/ddh106. View

10.

Mahoney Jr W, Hong J, Yaffe M, Farrance I . The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J. 2005; 388(Pt 1):217-25. PMC: 1186710. DOI: 10.1042/BJ20041434. View

11.

Chan S, Lim C, Shen Loo L, Chong Y, Huang C, Hong W . TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem. 2009; 284(21):14347-58. PMC: 2682883. DOI: 10.1074/jbc.M901568200. View

12.

Sawada A, Kiyonari H, Ukita K, Nishioka N, Imuta Y, Sasaki H . Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol Cell Biol. 2008; 28(10):3177-89. PMC: 2423158. DOI: 10.1128/MCB.01759-07. View

13.

Chen L, Chan S, Zhang X, Walsh M, Lim C, Hong W . Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev. 2010; 24(3):290-300. PMC: 2811830. DOI: 10.1101/gad.1865310. View

14.

Yagi R, Kohn M, Karavanova I, Kaneko K, Vullhorst D, DePamphilis M . Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development. 2007; 134(21):3827-36. DOI: 10.1242/dev.010223. View

15.

Zhao B, Kim J, Ye X, Lai Z, Guan K . Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res. 2009; 69(3):1089-98. DOI: 10.1158/0008-5472.CAN-08-2997. View

16.

Anbanandam A, Albarado D, Nguyen C, Halder G, Gao X, Veeraraghavan S . Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain. Proc Natl Acad Sci U S A. 2006; 103(46):17225-30. PMC: 1859914. DOI: 10.1073/pnas.0607171103. View

17.

Zhang H, Liu C, Zha Z, Zhao B, Yao J, Zhao S . TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem. 2009; 284(20):13355-13362. PMC: 2679435. DOI: 10.1074/jbc.M900843200. View

18.

Kitagawa M . A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ. Biochem Biophys Res Commun. 2007; 361(4):1022-6. DOI: 10.1016/j.bbrc.2007.07.129. View

19.

Nolte R, Wisely G, Westin S, Cobb J, Lambert M, Kurokawa R . Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 1998; 395(6698):137-43. DOI: 10.1038/25931. View

20.

Vassilev A, Kaneko K, Shu H, Zhao Y, DePamphilis M . TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 2001; 15(10):1229-41. PMC: 313800. DOI: 10.1101/gad.888601. View